Home Collection91115-91115

PRE-ECLAMPSIA SCREEN WITH PAPP-A AND PLGF,SERUM

This screening test assesses the risk of preeclampsia in pregnancy by measuring PAPP-A and PlGF levels in maternal serum. It helps in early identification of women at risk for complications.

Also known asMaternal Screening - Preeclampsia Screening With Papp-a And PlgfSerum Maternal Screening - Preeclampsia Screening With Papp-a And PlgfSerum

Available via

Home Collection, Lab Visit

Contains

11 parameters

Earliest reports in

5 Working Days

Test details
Preparations

No special preparations needed

Test included
PRE-ECLAMPSIA SCREEN WITH PAPP-A AND PLGF,SERUM includes 11 parameters

  • Pregnancy Associated Plasma Protein (papp-a)
  • Placental Growth Factor (plgf)
  • Uterine Arterial Pulsatility Index (utpi)
  • Mean Arterial Pressure (map)
  • Corrected Papp-a Mom
  • Corrected Plgf Mom
  • Corrected Utpi Mom
  • Corrected Map Mom
  • Preeclampsia Screening < 32 Week
  • Preeclampsia Screening < 34 Week
  • Preeclampsia Screening < 37 Week

Test code

10869

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
SerumYellow Vacutainer3 ML

Specimen stability information

Serum

Collection instructions

Risk assessment is calculated between gestation 11-14.1 weeks in first trimester. Referring physicians name, contact detail and duly filled Maternal consent form is mandatory (Maternal Date of Birth,Maternal Weight, Maternal Race, duplicate readings of blood pressure for both arms, left and right pulsatility index (UTPI),Maternal H/O Type I Diabetes Mellitus + Obstetric USG Report between 11 to 13.6 weeks of gestation+Date of collection).

Specimen rejection criteria

Test run frequency

Tuesday,Friday TIME - 09:00

Turn around time

5 Working Days

Performing locations

Department

  • Endocrinology

CPT and Loinc codes

PRE-ECLAMPSIA SCREEN WITH PAPP-A AND PLGF,SERUM

₹3000